Jyong Biotech Ltd. Ordinary Shares

MENS

$ -

Review earnings summary, surprise history, and upcoming forecasts.

account_balance_walletEarnings Summary

Updated: 12/31/2025FY2025 Q4

Revenue (TTM)

0M USD

YoY -

Net Income (TTM)

-3M USD

YoY Expanded Deficit

Equity Ratio

-119.9%

YoY +453.8pt

BPS

-0.34$

YoY Reduced Deficit

Revenue

FY2023 Q4$0

FY2024 Q1$0

FY2024 Q2$0

FY2024 Q3$0

FY2024 Q4$0

FY2025 Q2$0

FY2025 Q3$0

FY2025 Q4$0

Actual

YoY$0 (-)

Net Income

$-4.7M

FY2023 Q4$-1,329

$-1,329

FY2024 Q1$-663

$-663

Surprise History

Actual RevenueAnalyst Estimate

FY2020

Actual:$0

FY2020

FY2021